Core Viewpoint - Ying Tai Medical (01501) has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H-shares, indicating a strategic move to enhance liquidity and market presence [1] Group 1: Company Actions - The company has applied to convert a total of 71.7866 million domestic shares held by certain shareholders into H-shares for listing on the Hong Kong Stock Exchange [1] - The conversion and listing of these domestic shares as H-shares will occur once all necessary approvals from regulatory bodies, including the CSRC and the Stock Exchange, are obtained [1] - According to the company's articles of association, there is no requirement to hold a shareholders' meeting to approve the conversion and listing [1]
瑛泰医疗(01501)建议实施H股全流通